BLMN vs GILD · P/E 32, rev $2.08B vs P/E 18, rev $7.80B
Bloomin Brands Inc (BLMN) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Bloomin Brands Inc (BLMN) is a restaurants company listed on NASDAQ.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported BLMN revenue for 2026-06-28 was $2.08B. Net income was $87.0M. Revenue was up 95.9% from 2026-03-29 to 2026-06-28. BLMN currently screens at market cap $657.5M and trailing P/E 32.0.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
BLMN currently screens at market cap $657.5M and trailing P/E 32.0. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the BLMN and GILD stock pages for the full models.
Not investment advice.